Pharmacokinetics of intranasal mometasone in the fixed dose combination GSP301 versus two monotherapy intranasal mometasone formulations

Patel, P; Salapatek, AM; Talluri, RS; Tantry, SK

Patel, P (reprint author), 1310 Fewster Dr, Mississauga, ON L4W 1A4, Canada.

ALLERGY AND ASTHMA PROCEEDINGS, 2018; 39 (3): 232

Abstract

Background: GSP301 is a fixed-dose combination (FDC) of the antihistamine olopatadine hydimchloride and the corticosteroid mometasone furoate develope......

Full Text Link